General Electric Company, Valeant Pharmaceuticals Intl Inc.: Billionaire William Ackman’s Recent Comments
U.S. stock market have endured wild swings over the past few months, and some may wonder what has been driving equities so violently.
Posts Tagged ‘NYSE:VRX’
What Hedge Funds Think of Valeant as It Tries to Increase Shareholder Value?
In two separate articles published this weekend, the New York Times noted how Valeant Pharmaceuticals Intl Inc (NYSE:VRX) management has cut R&D, raised drug prices, and avoided...
Valeant Could Face Subpeona But Here’s Why You Should Buy It Anyway
You can add millions of angry (and poorer) investors to the list of people who really dislike Martin Shkreli at the moment.
Here’s Why Hedge Funds Like Valeant Pharmaceuticals Intl Inc (VRX)
Barring for a few tech names, there are very large-cap stocks that can match the returns that the stock of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has generated over the past...
Billionaires See A Healthy Future For These Healthcare Stocks
The S&P 500 Health Care Index has advanced by 21.11% over the past three-year period, which is significantly higher than the S&P 500’s return of 10.30% over the same time span...
Ackman Still Confident Herbalife Ltd. (HLF) Will Fall; Discusses Mondelez International Inc (MDLZ), Valeant Pharmaceuticals Intl Inc (VRX)
Renowned activist investor Bill Ackman of Pershing Square was having another one of his wonderful years, clocking in a gross return of 13.0% on a year-to-date basis through July...
Hedge Funds Are Hoarding Shares Of These Large-Caps
With the latest round of 13F filings in the books, hedge funds’ moves relating to different stocks and sectors during the second quarter are now available to those with the ...
Billionaire Paulson’s Top Healthcare Picks Include Allergan PLC (AGN), Valeant Pharmaceuticals Intl Inc (VRX) & Shire PLC (ADR) (SHPG)
John Paulson’s Paulson & Co. is a hedge fund that specializes in credit strategies, mergers, and event-driven arbitrage. Paulson & Co.
ValueAct Capital’s Top Stock Picks Heading Into Q3
In its most recent 13F filing with the SEC for the reporting period quarter ending June 30, Jeffrey Ubben's ValueAct capital revealed an equity portfolio worth nearly $19 billion...
Apple Inc. (AAPL), Valeant Pharmaceuticals Intl Inc (VRX) Among Steadfast Capital’s Top New Picks
Robert Pitts' Steadfast Capital Management recently filed its 13F with the Securities and Exchange Commission (SEC).
Billionaire Halvorsen and John Lykouretzos Are Betting On The Same Stocks
Both Andreas Halvorsen and John Lykouretzos are former Tiger Cubs who once traded equities at Julian Robertson’s Tiger Management hedge fund.
Zoetis Inc (ZTS) Tumbles After Acquisition Rumors Prove To Be Unfounded
Insider Monkey got drawn into what is happening in the market with regards to Zoetis Inc (NYSE:ZTS) after The Wall Street Journal released a report that Valeant Pharmaceuticals...
Bullish Sign: Billionaires Lee Ainslie and Mandel Are Investing In These Stocks
High-ranking investment managers often show similar interest in stock investments with common positions in multiple companies.
Will Apple Inc. (AAPL) Ever Be Dethroned In Robert Raiff’s Portfolio?
Robert Raiff has been known for a long time for his investment in traditional value stocks, carefully selecting companies that have attractive cash flow and little or no debt.
Ubben Takes Big Profit From Valeant Pharmaceuticals International Inc. (VRX) Stake, Sells Over 4.3 Million Shares
Activist hedge fund firm ValueAct Capital, has filed a 13D with the SEC revealing its ownership stake in Valeant Pharmaceuticals International Inc.
Billionaire Rosenstein’s Large-Cap Stock Picks and Why You Should Pay Attention
Barry Rosenstein of JANA Partners is one of the most visible activist investors in the U.S, one who targets both small and large-cap companies.
Healthcare Stocks Poised To Explode? Billionaire Investors Are Betting On These
Insider Monkey strives to always keep investors updated on diverse stocks across different industries.
5 Most Popular Healthcare Stocks Among Hedge Funds
According to a recent study by CIT, a reputable firm that is involved in financing and advisory services to the healthcare sector, healthcare executives seem rather optimistic...
Billionaire Stephen Mandel’s Top Picks: Priceline Group Inc (PCLN), JD.Com Inc (ADR) (JD), Mastercard Inc (MA) & Valeant Pharmaceuticals Intl Inc (VRX)
Billionaire Stephen Mandel’s Lone Pine Capital has recently disclosed its equity portfolio in its latest 13F filing with the U.S.
Billionaire Ackman Loves Valeant Pharmaceuticals Intl Inc (VRX), Air Products & Chemicals Inc. (APD), Canadian Pacific Railway Limited (USA)(CP)
In its latest 13F filing with the U.S.
Medtronic PLC (MDT), Actavis plc (ACT): Zweig-DiMenna Partners Top Picks from Healthcare Sector
Zweig-DiMenna Partners is a US-based hedge fund managed by Joseph A. DiMenna, who co-founded the fund with Martin Zweig back in 1984.
Jeffrey Ubben Has a Surprise Entry Among His Top Stock Picks
It is not every quarter that you get to spot drastic changes in the equity portfolio of Jeffrey Ubben's ValueAct Capital.
Sealed Air Corp. (SEE), Grace (W.R.) & Co. (GRA): Iridian Asset Management Discloses 13F Portfolio for Q2
David Cohen and Harold Levy are founders of Iridian Asset Management. Messrs.
Valeant Pharmaceuticals Intl Inc (VRX), Apple Inc. (AAPL), McDonald’s Corporation (MCD): A Look At Locust Wood’s Major First Quarter Moves
Hedge funds have started submitting their 13F filings with the SEC, offering other investors a chance to look at their equity holdings as of the end of the first quarter.
Billionaire Andreas Halvorsen’s New Healthcare Pick
As a new filing with the Securities and Exchange Commission showed, Andreas Halvorsen's Viking Global has initiated a new position in Envision Healthcare Holdings Inc (NYSE:EVHC...
Microsoft Corporation (MSFT), Valeant Pharmaceuticals Intl Inc (VRX): Partner Fund Management’s Winning Bets in Healthcare and Tech
Headquartered in San Francisco, Partner Fund Management was established in 2004 by Christopher Medlock James.
Valeant Pharmaceuticals (VRX), CBS Corporation (CBS) and Sirius XM Holdings (SIRI) Pushed This Hedgie to 11.5% Q1 Returns
The equity portfolio of Peter Adam Hochfelder’s Brahman Capital enjoyed a strong first quarter, with its 13 long positions in companies valued at $1 billion or more delivering...
eBay Inc (EBAY), Yahoo! Inc. (YHOO), Valeant Pharmaceuticals (VRX): Ivory Capital Continues to Perform Well in Relative Anonymity
The founder of Ivory Capital, Curtis Macnguyen may have a bone to pick with his fellow hedge fund managers, whose investment skills might not be better than his own, though they...
Activist Jeffrey Ubben’s Picks Blow Away S&P 500 Index in Q1
Activist Jeffrey Ubben's 14 picks in companies with a market cap of $1 billion or more (his entire portfolio) delivered weighted average returns of 8.1% in the first quarter.
Tiger Ratan Trumps Hedge Fund Industry in Q1; See How Nehal Chopra’s Stock Picks Performed
As the global hedge fund industry has swelled to almost $3.0 trillion in assets under management, it has become harder for fund managers to generate alpha in order to justify ...
Valeant Pharmaceuticals Intl Inc (VRX), Ctrip.com International, Ltd. (ADR) (CTRP): Hound Partners’ Picks Absolutely Destroyed The Market in Q1
Jonathan Auerbach’s Hound Partners had a very strong first quarter based on the 19 long positions in companies with a market cap of $1 billion or greater that it reported ownership...
Billionaire Halvorsen’s Picks Dominated S&P 500 Index in Q1: Alibaba Group Holding Ltd (BABA), Valeant and More
Andreas Halvorsen's long stock positions as disclosed in Viking Global's latest 13F filing had a solid first quarter as they delivered an average return of 6.2% based on our...
Billionaire Lee Ainslie Shows His Investing Acumen In Winners And Losers: Stock Picks Up 8.4% in Q1
Lee Ainslie’s Maverick Capital had one excellent quarter.
Billionaire Stephen Mandel’s Picks Crushed The Market in Q1 With 43 Stocks Returning 6%
Billionaire Stephen Mandel of Lone Pine Capital outperformed the market during the first quarter, with 43 stocks with a market cap of over $1.0 billion in which the investor reported...
Actavis plc (ACT), Valeant Pharmaceuticals Intl Inc (VRX) & More: Top Healthcare Picks Among Hedge Funds Crushed Mr. Market
The first quarter of 2015 is over and before hedge funds start releasing their Form 13F filings over the next 45 days, we will take a look at the performance of the stocks they...
Twitter Inc (TWTR), Kraft Foods Group Inc (KRFT), Valeant Pharmaceuticals Intl Inc (VRX): The 3 Biggest Large Cap Gainers of the First Quarter
The first quarter of 2015 is now officially in the books, and April Fools is upon us (there will be no trickery on our pages today, we promise).
Charter Communications, Inc. (CHTR): Ratan Capital Group Stays Hot As Stock Soars on Bright House Purchase
Nehal Chopra’s Ratan Capital Group has been one of the most successful hedge funds over the past two years, posting net returns of 22.3% in 2014 when the average hedge fund ...
With New Valeant Pharmaceuticals Intl Inc (VRX) Stake, Bill Ackman Maintains Large Exposure to Healthcare Sector
In a new filing with the US Securities and Exchange Commission, activist investor Bill Ackman's Pershing Square disclosed a significant long position in Valeant Pharmaceuticals...
DURECT Corporation (DRRX): First Eagle Raises Its Stake; See Investor’s Other Healthcare Picks
As a new filing with the Securities and Exchange Commission showed, Jean-Marie Eveillard's First Eagle Investment Management has increased its stake in DURECT Corporation (NASDAQ...
Pitney Bowes Inc. (PBI) and Theravance Inc (THRX)’s Stakes Further Rise In Iridian’s Portfolio
In two recently amended filings David Cohen and Harold Levy's Iridian Asset Management has disclosed further increasing its passive stakes in Theravance Inc (NASDAQ:THRX) to...
Here is How JANA Partners Returned 6.7% in February
JANA Partners is known for its activist campaigns.
Mallinckrodt PLC (MNK), Pfizer Inc. (PFE): Healthcor Management’s Top 5 Health Stocks
Arthur B. Cohen and Joseph Healey’s Healthcor Management LP recently filed its latest 13F with the SEC, disclosing its equity positions at the end of 2014.
Illumina, Inc., Walgreens Boots Alliance Inc, Valeant Pharmaceuticals Intl Inc: Billionaire Halvorsen’s Top 3 Picks
Andreas Halvorsen’s Viking Global disclosed its top three picks for the past quarter in a 13F Form filed with the U.S. Securities and Exchange Commission.
10 Most Popular Healthcare Stocks Among Hedge Funds
With the business of analyzing and compiling the data of our 737 tracked hedge funds’ latest 13F filings behind us, we’re ready to start sharing some of the findings from ...
Illumina, Inc. (ILMN), Pioneer Natural Resources (PXD), Valeant Pharmaceuticals Intl Inc (VRX): Can Andreas Halvorsen’s Top Picks Outperform Mr. Market?
Viking Global has been launched around 15 years ago by Tiger Cub Andreas Halvorsen, a former employee of Julian Robertson's Tiger Management and it managed to grow to over $25...
Valeant Pharmaceuticals Intl Inc (VRX): ValueAct Keeps Its Promise and Buys More Shares
In a new filing with the Securities and Exchange Commission, Jeff Ubben's ValueAct Capital reported increasing its position in Valeant Pharmaceuticals Intl Inc (NYSE:VRX).
Actavis plc (ACT), Allergan, Inc. (AGN), Pfizer Inc. (PFE): Hedge Funds Betting Big on Healthcare Stocks
One of the sectors that has benefited from the highest returns over the years is Healthcare.
Bill Ackman Is A Winner: Valeant Pharmaceuticals Intl Inc. (VRX), Allergan Inc. (AGN), Actavis plc (ACT)
Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) could lose out on a deal to acquire Botox Maker Allergan, Inc.
Is Zoetis Inc (ZTS) Bill Ackman’s Back-up Plan for Valeant Pharmaceuticals Intl Inc (VRX)?
As it was previously rumored in many sources, Bill Ackman's Pershing Square took a massive position in Zoetis Inc (NYSE:ZTS), as reported in a new filing with the US Securities...
